131 related articles for article (PubMed ID: 11701097)
1. The clinical effectiveness and cost-effectiveness of pioglitazone for type 2 diabetes mellitus: a rapid and systematic review.
Chilcott J; Wight J; Lloyd Jones M; Tappenden P
Health Technol Assess; 2001; 5(19):1-61. PubMed ID: 11701097
[No Abstract] [Full Text] [Related]
2. Economic evaluation of pioglitazone hydrochloride in the management of type 2 diabetes mellitus in Canada.
Coyle D; Palmer AJ; Tam R
Pharmacoeconomics; 2002; 20 Suppl 1():31-42. PubMed ID: 12036382
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of combination therapy with pioglitazone for type 2 diabetes mellitus from a german statutory healthcare perspective.
Neeser K; Lübben G; Siebert U; Schramm W
Pharmacoeconomics; 2004; 22(5):321-41. PubMed ID: 15061682
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the clinical effectiveness of pioglitazone in the treatment of type 2 diabetes mellitus.
Chilcott J; Tappenden P; Jones ML; Wight JP
Clin Ther; 2001 Nov; 23(11):1792-823; discussion 1791. PubMed ID: 11768834
[TBL] [Abstract][Full Text] [Related]
5. Does hypertriglyceridemia present an indication for pioglitazone therapy in diabetes?
Kane JP
Diabetes Technol Ther; 2002; 4(2):153-5. PubMed ID: 12079618
[No Abstract] [Full Text] [Related]
6. Pioglitazone and rosiglitazone for diabetes.
Drug Ther Bull; 2001 Sep; 39(9):65-8. PubMed ID: 11586802
[TBL] [Abstract][Full Text] [Related]
7. FDA approves pioglitazone for diabetes.
Miller JL
Am J Health Syst Pharm; 1999 Sep; 56(17):1698. PubMed ID: 10512494
[No Abstract] [Full Text] [Related]
8. Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.
Krentz AJ; Bailey CJ; Melander A
BMJ; 2000 Jul; 321(7256):252-3. PubMed ID: 10915108
[No Abstract] [Full Text] [Related]
9. Improvement of asthma after administration of pioglitazone.
Hashimoto Y; Nakahara K
Diabetes Care; 2002 Feb; 25(2):401. PubMed ID: 11815521
[No Abstract] [Full Text] [Related]
10. Improving management of type 2 diabetes mellitus: 5. Thiazolidinediones.
Samraj GP; Kuritzky L; Quillen DM
Hosp Pract (1995); 2000 Jan; 35(1):123-4, 129-32. PubMed ID: 10645993
[No Abstract] [Full Text] [Related]
11. Diabetes. Type-righting lessons.
Bryan J
Health Serv J; 2000 Nov; 110(5733):suppl 11-2. PubMed ID: 11138528
[No Abstract] [Full Text] [Related]
12. Thiazolidinediones in the treatment of type 2 diabetes.
Pittas AG; Greenberg AS
Expert Opin Pharmacother; 2002 May; 3(5):529-40. PubMed ID: 11996632
[TBL] [Abstract][Full Text] [Related]
13. Cost of Troglitazone therapy.
Bachman KH
Arch Intern Med; 1998 May; 158(9):1038. PubMed ID: 9616110
[No Abstract] [Full Text] [Related]
14. Thiazolidinediones in the treatment of type 2 diabetes: a clinician's perspective.
Buse JB
Am J Manag Care; 2000 Aug; 6(13 Suppl):S710-7. PubMed ID: 11183423
[No Abstract] [Full Text] [Related]
15. Actos (pioglitazone): a new treatment for type 2 diabetes.
Lawrence JM; Reckless JP
Hosp Med; 2001 Jul; 62(7):411-6. PubMed ID: 11480129
[TBL] [Abstract][Full Text] [Related]
16. Lack of effect of pioglitazone on postprandial triglyceride levels in type 2 diabetes.
Shimono D; Kuwamura N; Nakamura Y; Koshiyama H
Diabetes Care; 2001 May; 24(5):971. PubMed ID: 11347775
[No Abstract] [Full Text] [Related]
17. Pioglitazone.
Lawrence JM; Reckless JP
Int J Clin Pract; 2000 Nov; 54(9):614-8. PubMed ID: 11220991
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone: the future.
Brunetti P
Int J Clin Pract Suppl; 2001 Sep; (121):36. PubMed ID: 11594244
[No Abstract] [Full Text] [Related]
19. Pharmacologic therapy for type 2 diabetes mellitus.
DeFronzo RA
Ann Intern Med; 2000 Jul; 133(1):73-4. PubMed ID: 10877745
[No Abstract] [Full Text] [Related]
20. The glitazones: proceed with caution.
Krische D
West J Med; 2000 Jul; 173(1):54-7. PubMed ID: 10903299
[No Abstract] [Full Text] [Related]
[Next] [New Search]